BeOne Medicines
Tracked across 3 events · 18 articles · First seen Apr 13, 2026 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
BeOne Medicines, a global oncology company, was named 'Outstanding Global Oncology Company of the Year' at the HKCT Business Awards 2026, organized by the Hong Kong Commercial Times. This award acknowledges BeOne Medicines' significant progress…
Impact: BeOne Medicines received the 'Outstanding Global Oncology Company of the Year' award, recognizing its advancements in R&D and manufacturing of cancer therapies, which positively impacts its reputation and market standing.
May 11, 2026 · 6 articles
Tech
Impact: BeOne Medicines provided Tislelizumab under a clinical drug supply agreement for AnBogen Therapeutics's Phase 1/2 clinical trial.
Apr 13, 2026 · 6 articles
Business
AstronauTx, a biotechnology company focused on treating Alzheimer's Disease and other neurological disorders, announced the appointments of Dr. Michelle Mellion as Chief Medical Officer (CMO) and Deb Gouveia as Vice President, Clinical Operations and Development…
Impact: Dr. Michelle Mellion previously held a Chief Medical Officer role at BeOne Medicines, leading clinical development efforts.
May 12, 2026 · 6 articles
100
BeOne Medicines received award Hong Kong Commercial TimesBeOne Medicines Wins HKCT...
60
United States — Food and Drug Administration granted Priority Review BeOne MedicinesBeOne Medicines Wins HKCT...
50
BeOne Medicines submitted marketing application European Union — European Medicines AgencyBeOne Medicines Wins HKCT...
NEWSDESK
Track BeOne Medicines live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard